Haemonetics (HAE) said its second-quarter net income rose to $18.05 million or $0.69 per share from $14.81 million or $0.57 per share in the comparable period. Non-GAAP net income for the latest quarter grew to $18.05 million or $0.69 per share from $15.01 million or $0.58 per share last year. On average, 8 analysts polled by Thomson Reuters expected earnings per share of $0.65 for the quarter. Analysts' estimate typically excludes one-time items.
Net revenues for the second quarter increased 7.6% to $157.07 million from $145.92 million last year. Six analysts estimated revenues of $157.84 million. Haemonetics expects full-year Platelet revenue growth in a range of 0-2%. The company confirmed its full-year guidance of 8-11% revenue growth and earnings per share in a range of $2.75 - $2.85. Eight analysts expect earnings per share of $2.81 for the full year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.